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A B S T R A C T
This is the protocol for a review and there is no abstract. The objectives are as follows:
The main objective of this review is to evaluate the effectiveness of interventions to improve breastfeeding rates in women who are
overweight or obese.
We will also examine the effectiveness of different types of interventions based on the intervention delivery format (individual or
group and face-to-face or mobile technology); style (proactive or reactive); intensity; provider (peer or professional workers); setting
(community or hospital, Baby Friendly Initiative accredited; background breastfeeding initiation rate); timing (antenatal, postnatal
or both); and co-morbidities (without complications or with gestational diabetes mellitus or pre-existing diabetes, caesarean section,
preterm birth).
B A C K G R O U N D
Description of the condition
The World Health Organization (WHO) recommends that in-
fants are exclusively breastfed until six months of age with con-
tinued breastfeeding thereafter alongside appropriate complemen-
tary foods, due to the many health benefits of breastfeeding for
both the mother and infant (WHO 2001). Infants fed with hu-
man milk substitutes are at increased risk of infections, asthma
(Eidelman 2012; Salone 2013; Lessen 2015), atopic dermatitis
(Eidelman 2012), some childhood leukaemias (Eidelman 2012;
Salone 2013), coeliac disease (Eidelman 2012; Lessen 2015), and
sudden infant death syndrome (Eidelman 2012; Salone 2013;
Lessen 2015). Long-term risks to the infant of not receiving breast
milk have also been demonstrated such as increased obesity, is-
chaemic heart disease, and type 1 and type 2 diabetes in later life
(Eidelman 2012; Salone 2013; Lessen 2015). For preterm infants
breastfeeding reduces the risk of developing necrotising enterocol-
itis (Eidelman 2012; Salone 2013; Lessen 2015). Mothers who do
not breastfeed their infant are at increased risk of breast cancer,
ovarian cancer (Eidelman 2012; Salone 2013; Lessen 2015), type
2 diabetes, postnatal depression (Eidelman 2012; Lessen 2015),
and osteoporosis (Lessen 2015). Mother-infant bonding is also
believed to be reduced if the mother does not breastfeed (Lessen
2015). There is much debate around the association between
breastfeeding and postnatal weight changes, with some finding
no association between breastfeeding and postpartum weight loss
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(Neville 2014) andothers showing lessweight losswhennot breast-
feeding (Lessen 2015).
The internationally recognised definition of being overweight is
having a body mass index (BMI) between 25.0 and 29.9 kg/m²,
and the definitionof obesity is a BMI of 30.0 kg/m² or over (WHO
2000). Other definitions also exist for different populations, most
notably theWHOdefinition for Asian populations (WHO 2004).
The rate of overweight and obesity across the globe continues to
rise, with 34.9% of women currently having a BMI ≥ 25 kg/m²
and 13.9% a BMI ≥ 30 kg/m² (Stevens 2012).
It is well-established within the literature that women who are
overweight or obese have poorer breastfeeding outcomes. It has
been shown that women with a raised BMI are less likely to intend
to breastfeed (Krause 2011) and a systematic review of maternal
obesity and breastfeeding has found that obese women plan to
breastfeed for a shorter time period than women with a BMI in
the normal range (Amir 2007). Numerous studies and reviews
have also found that compared to women with a BMI in the
normal range, women who are overweight or obese are less likely
to initiate breastfeeding, initiate breastfeeding later on average,
are less likely to breastfeed exclusively and breastfeed for a shorter
duration, even when confounders such as age, parity, method of
delivery, smoking, delayed lactogenesis and feeding intention are
adjusted for (Amir 2007; Mok 2008; Lepe 2011; Wojcicki 2011;
Thompson 2013; Hauff 2014). The most recent review suggests
that women who have a BMI > 30 kg/m² have a 13% decreased
rate of breastfeeding initiation and a 20% decreased likelihood of
any breastfeeding at six months (Babendure 2015). The risk of
early discontinuation of any or full breastfeeding has been shown
to increase progressively with increasing BMI (Baker 2007). The
link between a high BMI and decreased initiation of breastfeeding
has also been shown regardless of gestational weight gain (Li 2003).
Several reasons have been proposed for why women who are over-
weight or obese are less likely to breastfeed. Factors believed to
impact on early breastfeeding success for women who are over-
weight or obese are mechanical factors and delayed lactogenesis
(Babendure 2015). Some women who are obese have larger breasts
than women with a BMI in the normal range, which canmake tra-
ditional breastfeeding positions more difficult (Babendure 2015).
Women who are obese have also been shown to experience in-
creased postpartum oedemawhich flattens the nipples, again mak-
ing it more difficult to latch an infant. Women who are obese hav-
ing more mechanical difficulties with breastfeeding is supported
by a study that has shown that prior to discharge from hospi-
tal and also at one and three months post-delivery, more women
who are obese than women with a BMI in the normal range re-
port breastfeeding problems such as cracked nipples, which are
associated with poor attachment (Mok 2008). Lactogenesis, the
production of copious milk, is triggered following the removal
of the placenta (Babendure 2015). For most women this occurs
within 72 hours of birth; however more women with a high BMI
have an onset of lactogenesis after 72 hours than women with a
BMI in the normal range (Hilson 2004). Even when other con-
founders are adjusted for, women who were overweight or obese
prior to pregnancy have been found to have a reduced prolactin
response to suckling at both 48 hours and seven days post-delivery
(Rasmussen 2004). Potential reasons for this delay in lactogenesis
in women who are obese are: i) the increased oedema experienced
by these women, which is linked to delayed lactogenesis; ii) an
increased likelihood of a prolonged labour and caesarean section.
This could be as the result of the release of leptin from adipose
tissue which inhibits oxytocin, which is the hormone needed both
for labour and the milk ejection reflex; iii) a less steep decline in
insulin concentrations from the end of pregnancy to initiation of
lactation in obese women. It is suggested that insulin is needed
for lactogenesis, so an insulin imbalance can influence the timing
of lactogenesis (Babendure 2015). The delay in lactogenesis de-
creases the mother’s confidence that her milk is sufficient for her
child, leading to early substitution and early cessation of breast-
feeding.Women with a raised BMI aremore likely to havemedical
complications such as gestational diabetes, a caesarean section or
a preterm birth (Marchi 2015), which have been linked with de-
layed lactogenesis (Amir 2007), reduced initiation of breastfeed-
ing (Thompson 2013), and increased risk of early termination of
full or any breastfeeding (Baker 2007). This may be in part due to
pregnancy complications making early separation of the mother
and infant more likely. However, even among those with medical
conditions that are known to decrease the breastfeeding rate, an
association between obesity and reduced breastfeeding continues
to exist (Babendure 2015).
Factors suggested to impact upon the duration of exclusive or
any breastfeeding for women who are obese include physiologi-
cal, anatomical and psychosocial (Babendure 2015). Free andro-
gens increase with increasing BMI and are particularly linked to
polycystic ovaries, which occurs more often in women who are
overweight or obese (Babendure 2015). Mid-pregnancy andro-
gen levels have been negatively correlated with breastfeeding du-
ration at both three and six months (Carlsen 2010). It is also
postulated that women who are overweight or obese may be so,
due to subclinical hypothyroidism. Thyroid hormones especially
levothyroxine (T4) and liothyronine (T3) are needed for the ini-
tiation and maintenance of breastfeeding (Babendure 2015). An-
imal studies have suggested that obesity in childhood negatively
affects the development of breast glandular tissue. Anatomically,
womenwho are overweight or obesemay therefore havemammary
hypoplasia/insufficient glandular tissue (Babendure 2015). Many
of the characteristics experienced by women who are overweight
or obese are consistent with this, including their reporting of in-
sufficient supply (Mok 2008), describing stopping breastfeeding
due to perceived insufficient supply (Guelinckx 2012), and being
more likely to try to express in the first two months postpartum
but less likely to have successfully expressed than women with
a normal BMI (Leonard 2011). Furthermore, no association be-
tween BMI and early cessation of breastfeeding has been shown
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for multiparous women who have successfully breastfed a child
previously (Kronborg 2012). This may suggest that the biological
factors associated with early cessation of breastfeeding had been
overcome in these women.
Psychosocial factors include confidence to reach breastfeeding
goals, feeding practices of friends and family,maternal self-efficacy
and body image (Babendure 2015). Women who are obese have
greater body dissatisfaction and lower self-esteem than women
with a BMI in the normal range, both of which could impact
upon breastfeeding intentions (Amir 2007).Womenwho are over-
weight or obese also usually belong to social classes that tradition-
ally breastfeed less, which may lead these women to feel more un-
comfortable about breastfeeding in public (Amir 2007). Indeed
one French study found mothers who were obese more often felt
uncomfortable about feeding in public or in front of others than
normal weight women and were less likely to seek breastfeeding
support in the first three months post-delivery (Mok 2008). How-
ever, psychosocial factors are not the sole contributor to lower
breastfeeding rates in women who are overweight or obese, as dif-
ferences in breastfeeding rates continue to exist after adjusting
for socio-cultural factors (Hauff 2014). Furthermore, research has
shown that while socio-economic status significantly influences
long-term breastfeeding, maternal BMI is consistently a signifi-
cant predictor of breastfeeding prior to six months (Soltani 2009).
Given that women who are overweight or obese have a lower inci-
dence of breastfeeding initiation and breastfeed for a shorter time
period, many clinicians and researchers have recognised the need
for additional encouragement and support forwomenwith a raised
BMI both during pregnancy and in the first year after delivery
to initiate and maintain breastfeeding (Mok 2008; Hesch Anstey
2011; Krause 2011; Babendure 2015). Establishing effective ways
to support women who are overweight or obese is of particular
importance, considering that the proportion of women who are
overweight and obese across the globe, including in developing
countries, continues to increase (Hossain 2007; Heslehurst 2010;
Stevens 2012).
Description of the intervention
This review evaluates interventions that could potentially increase
initiation or duration of breastfeeding in women who are over-
weight or obese. Various types of interventions exist which can be
delivered in combination or alone and in different settings (in hos-
pital or in the community and in services that are Baby Friendly
Initiative accredited or not). This review will include the following
intervention types.
1. Education. This provides women with information about
breastfeeding, including physiology, common concerns and their
management and an in depth description of the benefits of
breastfeeding for mothers and their babies. Education can be in a
variety of forms including - verbal and written and can be
delivered through different formats face-to-face in an individual
or group setting, online or through mobile applications. It is
usually provided in the antenatal period, but can also be
provided in the postnatal period or both in the antenatal and
postnatal periods.
2. Social support. This includes emotional, material or
financial, physical, reassurance, praise, networking and meeting
with others or the opportunity to discus and respond to a
woman’s questions. Support is usually provided in the postnatal
period, however initial contact with the woman can be in the
antenatal period. Support can be delivered by peer or
professional workers. This can include face-to-face support or
more remote forms of support such as telephone, Internet or
mobile technologies. It can be provided to women individually
or as part of a group and can be reactive responding to women’s
requests or proactive with scheduled visits. The level of support
can vary from one off support to ongoing support.
3. Physical interventions can include antenatal or postnatal
breast expression, and hospital practices such as encouragement
of skin-to-skin contact between mother and infant at delivery.
How the intervention might work
The support amother receives influences initiation andduration of
feeding, as does prenatal education and hospital practices (Lessen
2015).
A comprehensive taxonomy for the reporting of specific behaviour
change techniques incorporated within interventions has been de-
vised by Michie 2013. Within this taxonomy, educational inter-
ventions would use behaviour change techniques within the ’shape
knowledge’ cluster, through providing instructions on how to per-
form the behaviour such as providing advice on positioning and
attachment. Techniques within the ’natural consequences’ cluster
would also be utilised if information was provided on the health
consequences of breastfeeding. Social support falls within the ’so-
cial support’ cluster of behaviour change techniques and could also
contain behaviour change techniques within the ’reward and treat’
cluster if financial incentives or rewards are used. Physical inter-
ventions such as antenatal or postnatal breast expression aim to
improve lactogenesis by an early stimulation and hormonal release,
addressing concerns that women who are overweight or obese have
insufficient glandular tissue growth in the breasts.
Several reviews have been undertaken on interventions to support
breastfeeding. These have shown that any form of extra support
is effective at increasing any breastfeeding at six months postpar-
tum and on increasing exclusive breastfeeding at four to six weeks
(Renfrew 2012). In particular face-to-face and proactive support
were more likely to be successful, as were interventions in set-
tings with high breastfeeding initiation rates. A further review has
found educational- and support-based interventions are effective
at increasing exclusive breastfeeding at birth, one month and up
to fivemonths of age and at decreasing the rate of no breastfeeding
(Haroon 2013). Interventions that included both individual and
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group counselling were more effective than either an individual
or group intervention in isolation. Neither of these reviews have
however looked at what interventions are effective for women who
are overweight or obese. Due to the fact that women with a raised
BMI have different breastfeeding expectations and practices to
women with a BMI in the normal range (Mok 2008), and due to
the many possible factors noted above that can specifically influ-
ence the breastfeeding practices of women who are overweight or
obese (Babendure 2015), it is important to establish what inter-
ventions are most effective within this group of women.
Why it is important to do this review
The benefits to both the mother and the infant of breastfeed-
ing are well known (Eidelman 2012; Salone 2013; Lessen 2015).
It is also well-established within the literature that women who
are overweight or obese have different breastfeeding expectations,
practices and poorer breastfeeding outcomes than women with a
BMI in the normal range, including decreased breastfeeding initi-
ation and reduced breastfeeding length for both exclusive and any
breastfeeding (Hauff 2014; Babendure 2015). Physical, psycho-
logical, socio-cultural, medical and health services reasons have
been proposed for this disparity (Babendure 2015; Lessen 2015),
all of which mean that this group of women are in need of extra
support both in the antenatal period and post-delivery to initiate
and maintain breastfeeding. It is therefore essential to determine
the most beneficial methods of breastfeeding support for women
who are overweight or obese. The continuing global trend of in-
creased obesity both in the general and the obstetric populations
(Hossain 2007; Heslehurst 2010; Stevens 2012) make this issue
particularly important.
O B J E C T I V E S
The main objective of this review is to evaluate the effectiveness
of interventions to improve breastfeeding rates in women who are
overweight or obese.
We will also examine the effectiveness of different types of inter-
ventions based on the intervention delivery format (individual or
group and face-to-face or mobile technology); style (proactive or
reactive); intensity; provider (peer or professional workers); setting
(community or hospital, Baby Friendly Initiative accredited; back-
ground breastfeeding initiation rate); timing (antenatal, postnatal
or both); and co-morbidities (without complications or with ges-
tational diabetes mellitus or pre-existing diabetes, caesarean sec-
tion, preterm birth).
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised controlled trials, cluster-randomised trials and quasi-
randomised controlled studies will be included in this review. For
studies published in abstract form only, wewill contact the authors
for further details and the study will be included if sufficient data
are available on the study quality, intervention and outcomes of
interest. Studies using a crossover design will not be eligible for
inclusion in this review.
Types of participants
Participants will be any pregnant or lactating woman who is over-
weight or obese (as defined by trial authors based on pre-pregnancy
or booking pregnancy body mass index (BMI)) and has been re-
cruited into a trial where the intervention is aimed at supporting
breastfeeding, either initiation or maintenance. All women who
are overweight or obese will be included irrespective of co-existing
medical complications, e.g. diabetes, preterm delivery, caesarean
section.
Types of interventions
Any intervention specifically aimed at supporting mothers who
are overweight or obese to breastfeed which is over and above the
care usually provided within that setting.
Interventions may include social, educational, physical or other
support, or any combination of these.
Antenatal, postnatal or combined antenatal and postnatal inter-
ventions will be included so long as they are designed to improve
breastfeeding rates among women who are overweight or obese.
Interventions delivered at the level of the individual, in groups
or a combination of these will be included. Interventions may be
provided by either peer or professional workers and in hospital or
community settings.
Interventions can be compared either with each other or against a
control group which receives routine care for that setting.
Types of outcome measures
Primary outcomes
1. Intention to breastfeed.
2. Initiation of breastfeeding - defined as the baby being put
to the breast or being given any of the mother’s breast milk
within 48 hours of delivery (NHS England 2014).
3. Duration of exclusive breastfeeding.
4. Duration of any breastfeeding.
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Secondary outcomes
1. Maternal postpartum weight retention.
2. Maternal postpartum BMI.
3. Maternal satisfaction with care.
4. Maternal satisfaction with feeding method.
5. Maternal nipple health.
6. Mode of birth.
7. Infant weight gain.
8. All-cause infant or neonatal morbidity - as reported by trial
authors, for example, neonatal hypoglycaemia, low weight gain,
infections.
9. All-cause infant or neonatal mortality.
10. Gestational age.
11. Cost-effectiveness of the intervention.
Search methods for identification of studies
The following methods section of this protocol is based on a stan-
dard template used by the Cochrane Pregnancy and Childbirth
Group.
Electronic searches
We will search the Cochrane Pregnancy and Childbirth Group’s
Trials Register by contacting the Trials Search Co-ordinator.
The Register is a database containing over 20,000 reports of con-
trolled trials in the field of pregnancy and childbirth. For full
search methods used to populate the Pregnancy and Childbirth
Group’s Trials Register including the detailed search strategies for
CENTRAL, MEDLINE, Embase and CINAHL; the list of hand-
searched journals and conference proceedings, and the list of jour-
nals reviewed via the current awareness service, please follow this
link to the editorial information about the Cochrane Pregnancy
and Childbirth Group inThe Cochrane Library and select the ‘Spe-
cialized Register ’ section from the options on the left side of the
screen.
Briefly, the Cochrane Pregnancy and Childbirth Group’s Trials
Register is maintained by the Trials Search Co-ordinator and con-
tains trials identified from:
1. monthly searches of the Cochrane Central Register of
Controlled Trials (CENTRAL);
2. weekly searches of MEDLINE (Ovid);
3. weekly searches of Embase (Ovid);
4. monthly searches of CINAHL (EBSCO);
5. handsearches of 30 journals and the proceedings of major
conferences;
6. weekly current awareness alerts for a further 44 journals
plus monthly BioMed Central email alerts.
Search results are screened by two people and the full text of all
relevant trial reports identified through the searching activities de-
scribed above is reviewed. Based on the intervention described,
each trial report is assigned a number that corresponds to a spe-
cific Pregnancy and Childbirth Group review topic (or topics),
and is then added to the Register. The Trials Search Co-ordinator
searches the Register for each reviewusing this topic number rather
than keywords. This results in a more specific search set that will
be fully accounted for in the relevant review sections (Included,
Excluded, Awaiting Classification or Ongoing).
In addition, we will search ClinicalTrials.gov and the WHO In-
ternational Clinical Trials Registry Platform (ICTRP) for unpub-
lished, planned and ongoing trial reports using the terms given in
Appendix 1.
Searching other resources
We will search the reference lists of retrieved studies for further
eligible studies.
We will not apply any language or date restrictions.
Data collection and analysis
Selection of studies
Both review authors will independently assess for inclusion all the
potential studies we identify as a result of the search strategy. We
will resolve any disagreement through discussion or, if required,
we will consult a third person.
We will create a study flow diagram to map out the number of
records identified, included and excluded.
Data extraction and management
We will design a form to extract data. For eligible studies, both
review authors will extract the data using the agreed form.We will
resolve discrepancies through discussion. We will enter data into
ReviewManager software (RevMan 2014) and check for accuracy.
When information regarding any of the above is unclear, we will
attempt to contact authors of the original reports to provide further
details.
Assessment of risk of bias in included studies
Both review authors will independently assess risk of bias for each
study using the criteria outlined in the Cochrane Handbook for
Systematic Reviews of Interventions (Higgins 2011). We will resolve
any disagreement by discussion or by involving a third assessor.
In addition, if cluster-randomised trials are included we will as-
sess risk of (i) recruitment bias; (ii) baseline imbalance; (iii) loss of
clusters; (iv) incorrect analysis; and (v) comparability with indi-
vidually-randomised trials as outlined in the Cochrane Handbook
for Systematic Reviews of Interventions [Section 16.3.2] (Higgins
2011).
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(1) Random sequence generation (checking for possible
selection bias)
We will describe for each included study the method used to gen-
erate the allocation sequence in sufficient detail to allow an assess-
ment of whether it should produce comparable groups.
We will assess the method as:
• low risk of bias (any truly random process, e.g. random
number table; computer random number generator);
• high risk of bias (any non-random process, e.g. odd or even
date of birth; hospital or clinic record number);
• unclear risk of bias.
(2) Allocation concealment (checking for possible selection
bias)
We will describe for each included study the method used to con-
ceal allocation to interventions prior to assignment and will assess
whether intervention allocation could have been foreseen in ad-
vance of, or during recruitment, or changed after assignment.
We will assess the methods as:
• low risk of bias (e.g. telephone or central randomisation;
consecutively numbered sealed opaque envelopes);
• high risk of bias (open random allocation; unsealed or non-
opaque envelopes, alternation; date of birth);
• unclear risk of bias.
(3.1) Blinding of participants and personnel (checking for
possible performance bias)
For this type of intervention, blinding women and clinical staff is
generally not feasible, although itmay be possible to blind outcome
assessors.
(3.2) Blinding of outcome assessment (checking for possible
detection bias)
We will describe for each included study the methods used, if any,
to blind outcome assessors from knowledge of which intervention
a participant received. We will assess blinding separately for dif-
ferent outcomes or classes of outcomes.
We will assess methods used to blind outcome assessment as:
• low, high or unclear risk of bias.
(4) Incomplete outcome data (checking for possible attrition
bias due to the amount, nature and handling of incomplete
outcome data)
In studies examining breastfeeding support, women may be fol-
lowed up over many months. A cut-off of 20% missing data will
therefore be used to assess a study as low risk of bias. We will de-
scribe for each included study, and for each outcome or class of
outcomes, the completeness of data including attrition and exclu-
sions from the analysis. We will state whether attrition and exclu-
sions were reported and the numbers included in the analysis at
each stage (compared with the total randomised participants), rea-
sons for attrition or exclusion where reported, and whether miss-
ing data were balanced across groups or were related to outcomes.
Where sufficient information is reported, or can be supplied by
the trial authors, we will re-include missing data in the analyses
which we undertake.
We will assess methods as:
• low risk of bias (e.g. no missing outcome data; missing
outcome data balanced across groups; maximum of 20% missing
data);
• high risk of bias (e.g. numbers or reasons for missing data
imbalanced across groups; ‘as treated’ analysis done with
substantial departure of intervention received from that assigned
at randomisation);
• unclear risk of bias.
(5) Selective reporting (checking for reporting bias)
We will describe for each included study how we investigated the
possibility of selective outcome reporting bias and what we found.
We will assess the methods as:
• low risk of bias (where it is clear that all of the study’s pre-
specified outcomes and all expected outcomes of interest to the
review have been reported);
• high risk of bias (where not all the study’s pre-specified
outcomes have been reported; one or more reported primary
outcomes were not pre-specified; outcomes of interest are
reported incompletely and so cannot be used; study fails to
include results of a key outcome that would have been expected
to have been reported);
• unclear risk of bias.
(6) Other bias (checking for bias due to problems not
covered by (1) to (5) above)
We will describe for each included study any important concerns
we have about other possible sources of bias.
We will assess whether each study was free of other problems that
could put it at risk of bias:
• low risk of other bias;
• high risk of other bias;
• unclear whether there is risk of other bias.
(7) Overall risk of bias
We will make explicit judgements about whether studies are at
high risk of bias, according to the criteria given in the Handbook
(Higgins 2011). With reference to (1) to (6) above, we will assess
the likely magnitude and direction of the bias and whether we
consider it is likely to impact on the findings. For the purpose of
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this review, ’high quality’ will be defined as a trial having adequate
sequence generation, allocation concealment and an attrition rate
of less than 20%. We will explore the impact of the level of bias
through undertaking sensitivity analyses - see Sensitivity analysis.
Assessing the quality of the body of evidence using
the GRADE approach
The quality of the evidence will be assessed using the GRADE ap-
proach as outlined in the GRADE handbook in order to assess the
quality of the body of evidence relating to the following outcomes
for the main comparisons.
1. Intention to breastfeed.
2. Initiation of breastfeeding.
3. Duration of exclusive breastfeeding.
4. Duration of any breastfeeding.
We will use the GRADEpro Guideline Development Tool to im-
port data from Review Manager 5.3 (RevMan 2014) in order to
create ’Summary of findings’ tables. A summary of the interven-
tion effect and a measure of quality for each of the above outcomes
will be produced using the GRADE approach. The GRADE ap-
proach uses five considerations (study limitations, consistency of
effect, imprecision, indirectness and publication bias) to assess the
quality of the body of evidence for each outcome. The evidence
can be downgraded from ’high quality’ by one level for serious (or
by two levels for very serious) limitations, depending on assess-
ments for risk of bias, indirectness of evidence, serious inconsis-
tency, imprecision of effect estimates or potential publication bias.
Measures of treatment effect
Dichotomous data
For dichotomous data, we will present results as summary risk
ratio with 95% confidence intervals.
Continuous data
For continuous data, we will use the mean difference if outcomes
are measured in the same way between trials. We will use the
standardised mean difference to combine trials that measure the
same outcome, but use different methods.
Unit of analysis issues
Cluster-randomised trials
We will include cluster-randomised trials in the analyses along
with individually-randomised trials. We will adjust their sample
sizes using the methods described in the Cochrane Handbook for
Systematic Reviews of Interventions [Section 16.3.4] (Higgins 2011)
using an estimate of the intracluster correlation co-efficient (ICC)
derived from the trial (if possible), from a similar trial or from a
study of a similar population. If we use ICCs from other sources,
we will report this and conduct sensitivity analyses to investigate
the effect of variation in the ICC. If we identify both cluster-
randomised trials and individually-randomised trials, we plan to
synthesise the relevant information. We will consider it reasonable
to combine the results from both if there is little heterogeneity
between the study designs and the interaction between the effect
of intervention and the choice of randomisation unit is considered
to be unlikely.
We will also acknowledge heterogeneity in the randomisation unit
and perform a sensitivity analysis to investigate the effects of the
randomisation unit.
Multiple-armed trials
We will include multi-armed trials and attempt to overcome po-
tential unit of analysis errors by combining groups to create a sin-
gle pair-wise comparison, or select one pair of interventions and
exclude the others as described in the Cochrane Handbook for Sys-
tematic Reviews of Interventions [Section 16.4.] (Higgins 2011).
Dealing with missing data
For included studies, wewill note levels of attrition.Wewill explore
the impact of including studies with high levels of missing data
in the overall assessment of treatment effect by using sensitivity
analysis.
For all outcomes, we will carry out analyses, as far as possible,
on an intention-to-treat basis, i.e. we will attempt to include all
participants randomised to each group in the analyses, and all
participants will be analysed in the group to which they were
allocated, regardless of whether or not they received the allocated
intervention. The denominator for each outcome in each trial
will be the number randomised minus any participants whose
outcomes are known to be missing.
Assessment of heterogeneity
We will assess statistical heterogeneity in each meta-analysis using
the Tau², I² and Chi² statistics. We will regard heterogeneity as
substantial if an I² is greater than 30%and either the Tau² is greater
than zero, or there is a low P value (less than 0.10) in the Chi² test
for heterogeneity.
Assessment of reporting biases
If there are 10 or more studies in the meta-analysis, we will in-
vestigate reporting biases (such as publication bias) using funnel
plots. We will assess funnel plot asymmetry visually. If asymmetry
is suggested by a visual assessment, we will perform exploratory
analyses to investigate it.
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Data synthesis
We will carry out statistical analysis using the Review Manager
software (RevMan 2014). We anticipate some heterogeneity be-
tween studies in terms of the intervention and study populations,
we will therefore use random-effects meta-analysis for combining
data. The random-effects analyses results will be presented as the
average treatment effect with 95% confidence intervals, and the
estimates of Tau² and I². The random-effects summary will be
treated as the average of the range of possible treatment effects and
we will discuss the clinical implications of treatment effects differ-
ing between trials. If the average treatment effect is not clinically
meaningful, we will not combine trials.
If we use random-effects analyses, the results will be presented as
the average treatment effect with 95% confidence intervals, and
the estimates of Tau² and I².
Subgroup analysis and investigation of heterogeneity
If we identify substantial heterogeneity, we will investigate it us-
ing subgroup analyses and sensitivity analyses. We will consider
whether an overall summary is meaningful, and if it is, use ran-
dom-effects analysis to produce it.
We plan to carry out the following subgroup analyses by:
1. BMI category (overweight versus obese);
2. intervention provider (professional versus partner/family
member/peer support);
3. type of intervention delivery (face-to-face versus remote
support; group versus individual);
4. timing of intervention (antenatal and postnatal versus
postnatal alone);
5. whether the intervention was proactive (scheduled contact)
versus reactive (contact requested by the woman);
6. setting of the intervention (Baby-Friendly Initiative
accredited institution versus non Baby-Friendly Initiative
accredited institution);
7. location of the intervention (hospital versus community);
8. intensity of intervention (number of scheduled contacts);
9. mode of delivery (normal vaginal delivery versus assisted/
operational birth (instrumental vaginal delivery and caesarean
section));
10. socio-economic status of the population (high and medium
versus low);
11. background breastfeeding initiation rates (high (≥ 80%)
and medium (60% to < 80%) versus low (< 60%));
12. co-morbidities (without complications versus with
gestational diabetes mellitus, pre-existing diabetes and preterm
birth).
Primary outcomes only will be used in the subgroup analysis.
We will assess subgroup differences by interaction tests available
within RevMan (RevMan 2014). We will report the results of
subgroup analyses quoting the Chi2 statistic and P value, and the
interaction test I² value.
Sensitivity analysis
We will carry out sensitivity analysis based on the quality of the
included trials to identify the impact of themethodological quality
on the overall results. For the purpose of this review, ’high quality’
will be defined as a trial having adequate sequence generation,
allocation concealment and an attrition rate of less than 25%. If
cluster-randomised trials are included, sensitivity analysis will also
be used to investigate the effect of variation in the ICC and to
investigate the effect of the unit of randomisation. We will restrict
sensitivity analyses to the primary outcomes.
A C K N OW L E D G E M E N T S
As part of the pre-publication editorial process, this protocol has
been commented on by three peers (an editor and two referees
who are external to the editorial team), a member of the Pregnancy
and Childbirth Group’s international panel of consumers and the
Group’s Statistical Adviser.
This project was supported by the National Institute for Health
Research, via Cochrane Infrastructure funding to Cochrane Preg-
nancy and Childbirth. The views and opinions expressed therein
are those of the authors and do not necessarily reflect those of the
Systematic Reviews Programme, NIHR, NHS or the Department
of Health.
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A P P E N D I C E S
Appendix 1. Search terms for ICTRP and ClinicalTrials.gov
breastfeeding AND obese
breastfeeding AND overweight
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